Purdue Pharma exit plan gains steam

OxyContin maker Purdue Pharma's plan to reorganize into an entity whose profits will be used to combat the U.S. opioid crisis got a big boost as 15 states dropped their objections to the new business model. (July 8)

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting